Konner J et al. |
Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma. |
2012 |
Invest New Drugs |
pmid:22072399
|
Monk JP et al. |
A phase 1 study of KOS-862 (Epothilone D) co-administered with carboplatin (Paraplatin®) in patients with advanced solid tumors. |
2012 |
Invest New Drugs |
pmid:21826439
|
Brunden KR et al. |
The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies. |
2011 |
Pharmacol. Res. |
pmid:21163349
|
Nakano M et al. |
Identification of glycan structure alterations on cell membrane proteins in desoxyepothilone B resistant leukemia cells. |
2011 |
Mol. Cell Proteomics |
pmid:21859949
|
Brunden KR et al. |
Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy. |
2010 |
J. Neurosci. |
pmid:20943926
|
Prantz K and Mulzer J |
Synthesis of (Z)-trisubstituted olefins by decarboxylative grob-type fragmentations: epothilone D, discodermolide, and peloruside A. |
2010 |
Chemistry |
pmid:19943284
|
Zhang SQ et al. |
Determination of a novel epothilone D analog (AV-EPO-106) in human plasma using ultra-performance liquid chromatography-tandem mass spectrometry. |
2009 |
Biomed. Chromatogr. |
pmid:18800336
|
Zhang C et al. |
Simultaneous determination of epothilone D and its hydrolytic metabolite in human plasma by high performance liquid chromatography-tandem mass spectrometry for pharmacokinetic studies. |
2009 |
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. |
pmid:19775943
|
Prantz K and Mulzer J |
Decarboxylative Grob-type fragmentations in the synthesis of trisubstituted Z olefins: application to peloruside A, discodermolide, and epothilone D. |
2009 |
Angew. Chem. Int. Ed. Engl. |
pmid:19492384
|
Frein JD et al. |
New sources of chemical diversity inspired by biosynthesis: rational design of a potent epothilone analogue. |
2009 |
Org. Lett. |
pmid:19572566
|